Skip to main content
PMC home page
Cancer Science logoLink to Cancer Science
. 2005 Aug 19;95(2):131–135. doi: 10.1111/j.1349-7006.2004.tb03193.x

Cloning of a G‐protein‐coupled receptor that shows an activity to transform NIH3T3 cells and is expressed in gastric cancer cells

Shun‐ichiro Okumura 1,2, Hiroko Baba 1,4, Tatsuro Kumada 1, Koji Nanmoku 1, Hirofumi Nakajima 1, Yasushi Nakane 2, Koshiro Hioki 2, Kazuhiro Ikenaka 1,✉
PMCID: PMC11159784  PMID: 14965362

Abstract

The present study was directed towards the identification of novel factors involved in the transformation process leading to the formation of gastric cancer. A cDNA library from human gastric cancer cells was constructed using a retroviral vector. Functional cloning was performed by screening for transformation activity in transduced NIH3T3 cells. Six cDNA clones were isolated, including one encoding the elongation factor 1asubunit, which was already known to play a role in tumorigenesis. One cDNA (clone 56.2), which was repeatedly isolated during the course of screening, encoded a protein identical to a G‐protein‐coupled receptor protein, GPR35. In addition, another cDNA clone (72.3) was found to be an alternatively spliced product of the GPR35 gene, whereby 31 amino acids were added to the N‐terminus of GPR35. Hence, the proteins encoded by clones 56.2 and 72.3 were designated GPR35a and GPR35b, respectively. RT‐PCR experiments revealed that GPR35 gene expression is low or absent in surrounding non‐cancerous regions, while both mRNAs were present in all of the gastric cancers examined. The level of 72.3‐encoded mRNA was consistently significantly higher than that of 56.2 encoded mRNA. An expression pattern similar to that observed in gastric cancers was detected in normal intestinal mucosa. Based on the apparent transformation activities of the two GPR35 clones in NIH3T3 cells, and the marked up‐regulation of their expression levels in cancer tissues, it is speculated that these two novel isoforms of GPR35 are involved in the course of gastric cancer formation.

References

  • 1. Maehara Y, Kusumoto T, Emi Y, Anai H, Sakaguchi Y, Kohnoe S, Sugimachi K. 5‐Fluorouracil is converted to F‐nucleotides more extensively and is more cytotoxic in poorly differentiated than in well differentiated human gastric carcinoma. Anticancer Res 1990; 10: 1091–4. [PubMed] [Google Scholar]
  • 2. Goseki N, Takizawa T, Koike M. Differences in the mode of the extension of gastric cancer classified by histological type: new histological classification of gastric carcinoma. Gut 1992; 33: 606–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Correa P. The new era of cancer epidemiology. Cancer Epidemiol Biomarkers Prev 1991; 1: 5–11. [PubMed] [Google Scholar]
  • 4. Semba S, Yokozaki H, Yamamoto S, Yasui W, Tahara E. Microsatellite instability in precancerous lesions and adenocarcinomas of the stomach. Cancer 1996; 77: 1620–7. [DOI] [PubMed] [Google Scholar]
  • 5. Yokozaki H, Kuniyasu H, Kitadai Y, Nishimura K, Todo H, Ayhan A, Yasui W, Ito H, Tahara E. p53 point mutations in primary human gastric carcinomas. J Cancer Res Clin Oncol 1992; 119: 67–70. [DOI] [PubMed] [Google Scholar]
  • 6. Nakatsuru S, Yanagisawa A, Ichii S, Tahara E, Kato Y, Nakamura Y, Horii A. Somatic mutation of the APC gene in gastric cancer: frequent mutations in very well differentiated adenocarcinoma and signet‐ring cell carcinoma. Hum Mol Genet 1992; 8: 559–63. [DOI] [PubMed] [Google Scholar]
  • 7. Hattori Y, Itoh H, Uchino S, Hosokawa K, Ochiai A, Ino Y, Ishii H, Sakamoto H, Yamaguchi N, Yanagihara K, Hirohashi S, Sugimura T, Terada M. Immunohistochemical detection of K‐sam protein in stomach cancer. Clin Cancer Res 1996; 8: 1373–81. [PubMed] [Google Scholar]
  • 8. Wong BY, Chen H, Chung SW, Wong PM. High‐efficiency identification of genes by functional analysis from a retroviral cDNA expression library. J Virol 1994; 68: 5523–31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. O'Dowd BF, Nguyen T, Marchese A, Cheng R, Lynch KR, Heng HH, Kolakowski LF Jr, George SR. Discovery of three novel G‐protein‐coupled receptor genes. Genomics 1998; 47: 310–3. [DOI] [PubMed] [Google Scholar]
  • 10. Chomczynski P, Sacchi N. Single‐step method of RNA isolation by acid guanidinium thiocyanate‐phenol‐chloroform extraction. Anal Biochem 1987; 162: 156–9. [DOI] [PubMed] [Google Scholar]
  • 11. Yoshimatsu T, Tamura M, Kuriyama S, Ikenaka K. Improvement of retroviral packaging cell lines by introducing the polyomavirus early region. Hum Gene Ther 1998; 9: 161–72. [DOI] [PubMed] [Google Scholar]
  • 12. Ikenaka K, Nakahira K, Nakajima K, Fujimoto I, Kagawa T, Ogawa M, Mikoshiba K. Detection of brain‐specific gene expression in brain cells in primary culture: a novel promoter assay based on the use of a retrovirus vector. New Biol 1992; 1: 53–60. [PubMed] [Google Scholar]
  • 13. Cepko C. Preparation of a specific retrovirus producer cell line. In: Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K, editors. Current protocols in molecular biology. Suppl. 17. New York : John Wiley and Sons; 1992. p. 9.111–12. [DOI] [PubMed] [Google Scholar]
  • 14. Gopalkrishnan RV, Su ZZ, Goldstein NI, Fisher PB. Translational infidelity and human cancer: role of the PTI‐1 oncogene. Int J Biochem Cell Biol 1999; 31: 151–62. [DOI] [PubMed] [Google Scholar]
  • 15. Foster KW, Ren S, Louro ID, Lobo‐Ruppert SM, McKie‐Bell P, Grizzle W, Hayes MR, Broker TR, Chow LT, Ruppert JM. Oncogene expression cloning by retroviral transduction of adenovirus E1A‐immortalized rat kidney RK3E cells: transformation of a host with epithelial features by c‐MYC and the zinc finger protein GKLF. Cell Growth Differ 1999; 10: 423–34. [PubMed] [Google Scholar]
  • 16. Graness A, Adomeit A, Heinze R, Wetzker R, Liebmann C. A novel mitogenic signaling pathway of bradykinin in the human colon carcinoma cell line SW‐480 involves sequential activation of a Gq/11 protein, phosphatidylinositol 3‐kinase beta, and protein kinase Cepsilon. J Biol Chem 1998; 273: 32016–22. [DOI] [PubMed] [Google Scholar]
  • 17. Antonelli V, Bernasconi F, Wong YH, Vallar L. Activation of B‐Raf and regulation of the mitogen‐activated protein kinase pathway by the G(o) alpha chain. Mol Biol Cell 2000; 11: 1129–42. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Marinissen MJ, Gutkind JS. G‐Protein‐coupled receptors and signaling networks: emerging paradigms. Trends Pharmacol Sci 2001; 22: 368–76. [DOI] [PubMed] [Google Scholar]
  • 19. Pai R, Soreghan B, Szabo IL, Pavelka M, Baatar D, Tarnawski AS. Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nat Med 2002; 8: 289–93. [DOI] [PubMed] [Google Scholar]
  • 20. Parry MA, Myles T, Tschopp J, Stone SR. Cleavage of the thrombin receptor: identification of potential activators and inactivators. Biochem J 1996; 320: 335–41. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Ruol A, Parenti A, Zaninotto G, Merigliano S, Costantini M, Cagol M, Alfieri R, Bonavina L, Peracchia A, Ancona E. Intestinal metaplasia is the probable common precursor of adenocarcinoma in Barrett esophagus and adenocarcinoma of the gastric cardia. Cancer 2000; 88: 2520–8. [DOI] [PubMed] [Google Scholar]
  • 22. Kobayashi K, Okamoto T, Takayama S, Akiyama M, Ohno T, Yamada H. Genetic instability in intestinal metaplasia is a frequent event leading to well‐differentiated early adenocarcinoma of the stomach. Eur J Cancer 2000; 36: 1113–9. [DOI] [PubMed] [Google Scholar]

Articles from Cancer Science are provided here courtesy of Wiley

RESOURCES